Prolonged survival of heart allografts transduced with AAV-CTLA41g

Microsurgery

Volumn 23, Issue 5, 2003, Pages 489-493

  Chen, Zongyou ^a   Lu, Lina ^a   Li, Juan ^b   Xiao, Xiao ^b   Fung, John J ^a   Qian, Shiguang ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CTLA-4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; HYBRID PROTEIN; IMMUNOSUPPRESSIVE AGENT; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; GRAFT REJECTION; GRAFT SURVIVAL; HEART MUSCLE; HEART TRANSPLANTATION; IMMUNOLOGY; MALE; METHODOLOGY; MOUSE; MOUSE STRAIN; MUSCLE CELL; NONHUMAN; ORGAN TRANSPLANTATION; PHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; DEPENDOVIRUS; GENETIC VECTORS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MODELS, ANIMAL; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC;

EID: 0142151560     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/micr.10181     Document Type: Conference Paper

References (37)

1. Afione SA, Conrad CK, Kearns WG, Chunduru S, Adams R, Reynolds TC, Guggino WB, Cutting GR, Carter BJ, Flotte TR. In vivo model of adeno-associated virus vector persistence and rescue. J Virol 1996;70:3235-3241.
2. Xiao X, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 1996;70:8098-8108.
3. Nicklin SA, Baker AH. Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy. Curr Gene Ther 2002;2:273-293.
4. Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998;72:2224-2232.
5. Chen D, Sung R, Bromberg JS. Gene therapy in transplantation. Transplant Immunol 2002;9:301-314.
6. Monahan PE, Samulski RJ. Adeno-associated virus vectors for gene therapy: more pros than cons? Mol Med Today 2000;6:433-440.
7. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993;11:191-212.
8. Bluestone JA. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 1995;2:555-559.
9. Thompson CB. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 1995;81:979-982.
10. Turka LA, Linsley PS, Lin H, Brady W, Leiden JM, Wei RQ, Gibson ML, Zheng XG, Myrdal S, Gordon D, Bailey T, Bolling SF, Thompson CB. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992;89:11102-11105.
11. Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, Turka LA. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993;178:1801-1806.
12. Pearson TC, Alexander DZ, Winn KJ, Linsley PS, Lowry RP, Larsen CP. Transplantation tolerance induced by CTLA4Ig. Transplantation 1994;57:1701-1706.
13. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ, Muzyczka N. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 1999;6:973-985.
14. Snyder R, Xiao X, Samulski RJ. Production of recombinant adeno-associated viral vectors. In: Dracopoli N, Haines J, Krof B, Moir D, Seidman C, Seidman J, Smith D, editors. Current protocols in human genetics. New York: John Wiley & Sons, Inc.; 1996. p 12.1.1-12.2.23.
15. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996;62:659-665.
16. Igarashi P, Shashikant CS, Thomson RB, White DA, Liu-Chen S, Ruddle FH, Aronson PS. Ksp-cadherin gene promoter. II. Kidney-specific activity in transgenic mice. Am J Physiol 1999;277:599-610.
17. Lu L, Gambotto A, Lee WC, Qian S, Bonham CA, Robbins PD, Thomson AW. Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients. Gene Ther 1999;6:554-563.
18. Kirk AD, Burkly LC, Batty DS, Baumgartner RE, Berning JD, Buchanan K, Fechner JH Jr, Germond RL, Kampen RL, Patterson NB, Swanson SJ, Tadaki DK, TenHoor CN, White L, Knechtle SJ, Harlan DM. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999;5:686-693.
19. Ossevoort MA, Ringers J, Kuhn EM, Boon L, Lorre K, van den Hout Y, Bruijn JA, de Boer M, Jonker M, de Waele P. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway. Transplantation 1999;68:1010-1018.
20. Pearson TC, Alexander DZ, Hendrix R, Elwood ET, Linsley PS, Win KJ, Larsen CP. CTLA4-Ig plus bone marrow induces longterm allograft survival and donor specific unresponsiveness in the murine model: evidence for hematopoietic chimerism. Transplantation 1996;61:997-1004.
21. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991;174:561-569.
22. Croxford JL, O'Neill JK, Ali RR, Browne K, Byrnes AP, Dallman MJ, Wood MJ, Feldmann M, Baker D. Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis. Eur J Immunol 1998;28:3904-3916.
23. Namii Y, Hayashi S, Yokoyama I. Evidence that the adenoviral vector containing the CTLA4-Ig gene improves transgene expression and graft survival. Transplant Proc 1997;29:1738-1739.
24. Tu Y, Rehman A, Flye MW. CTLA4-Ig treatment prolongs rat orthotopic liver graft survival. Transplant Proc 1997;29:1036-1037.
25. Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Goldfarb MT, Goffe BS, Menter A, Lowe NJ, Krueger G, Brown MJ, Weiner RS, Birkhofer MJ, Warner GL, Berry KK, Linsley PS, Krueger JG, Ochs HD, Kelley SL, Kang S. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest 1999;103:1243-1252.
26. Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S, Lebwohl MG, Guzzo CA, Jegasothy BV, Linsley PS, Krueger JG. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med 2000; 192:681-694.
27. Sayegh MH. Finally, CTLA4Ig graduates to the clinic. J Clin Invest 1999;103:1223-1225.
28. Barr E, Carroll J, Kalynych AM, Tripathy SK, Kozarsky K, Wilson JM, Leiden JM. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther 1994;1:51-58.
29. French BA, Mazur W, Geske RS, Bolli R. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 1994;90:2414-2424.
30. Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, Zeitlin PL, Guggino WB, Carter BJ. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 1993;90: 10613-10617.
31. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994;8:148-154.
32. Shimpo M, Ikeda U, Maeda Y, Ueno S, Ikeda M, Minota S, Takizawa T, Urabe M, Kume A, Monahan J, Ozawa K, Shimada K. Gene transfer into rat renal cells using adeno-associated virus vectors. Am J Nephrol 2000;20:242-247.
33. Maeda Y, Ikeda U, Ogasawara Y, Urabe M, Takizawa T, Saito T, Colosi P, Kurtzman G, Shimada K, Ozawa K. Gene transfer into vascular cells using adeno-associated virus (AAV) vectors. Cardiovasc Res 1997;35:514-521.
34. Kessler PD, Podsakoff GM, Chen X, McQuiston SA, Colosi PC, Matelis LA, Kurtzman GJ, Byrne BJ. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 1996;93:14082-14087.
35. Maeda Y, Ikeda U, Shimpo M, Ueno S, Ogasawara Y, Urabe M, Kume A, Takizawa T, Saito T, Colosi P, Kurtzman G, Shimada K, Ozawa K. Efficient gene transfer into cardiac myocytes using adeno-associated virus (AAV) vectors. J Mol Cell Cardiol 1998;30:1341-1348.
36. Wang B, Li J, Xiao X. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci USA 2000;97:13714-13719.
37. Berns KI. Parvoviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology.. Philadelphia: Lippincott-Raven; 1996. p 2173-2197.